124 related articles for article (PubMed ID: 7186116)
1. [Prolactin levels and indicators of breast cancer risk in women with mastopathy].
Teter J; Paszko Z; Gadomska H; Mach S; Kwiatkowska E
Nowotwory; 1982; 32(4):193-200. PubMed ID: 7186116
[No Abstract] [Full Text] [Related]
2. Mastodynia due to fibrocystic disease of the breast controlled with thyroid hormone.
Estes NC
Am J Surg; 1981 Dec; 142(6):764-6. PubMed ID: 7316045
[TBL] [Abstract][Full Text] [Related]
3. [Endocrine characteristics of women with fibrocystic mastopathy].
Melis GB; Guarnieri G; Paoletti AM; Cappelli N; Selli M; Petacchi FD; Ruju A; Fioretti P
Minerva Ginecol; 1982 Nov; 34(11):897-901. PubMed ID: 7155415
[No Abstract] [Full Text] [Related]
4. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
[TBL] [Abstract][Full Text] [Related]
5. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
[TBL] [Abstract][Full Text] [Related]
6. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
[TBL] [Abstract][Full Text] [Related]
7. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
[TBL] [Abstract][Full Text] [Related]
8. A review of the epidemiology of human breast cancer.
Kelsey JL
Epidemiol Rev; 1979; 1():74-109. PubMed ID: 398270
[TBL] [Abstract][Full Text] [Related]
9. [Mastopathy and breast cancer: is there a typical hormone profile?].
Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
[TBL] [Abstract][Full Text] [Related]
10. Fibrocystic "disease" of the breast.
N Engl J Med; 1983 Mar; 308(12):722-3. PubMed ID: 6828114
[No Abstract] [Full Text] [Related]
11. [Serum prolactin level in patients with mastopathy. Clinical significance].
Peters F; Breckwoldt M
Verh Dtsch Ges Pathol; 1985; 69():401-4. PubMed ID: 3938116
[No Abstract] [Full Text] [Related]
12. Prolactin and breast cancer risk.
Ingram DM; Nottage EM; Roberts AN
Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
[TBL] [Abstract][Full Text] [Related]
13. [Mastopathy and endometrial hyperplasia--coexistence, relationships].
Teter J; Szamborski J
Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):188-90. PubMed ID: 8084821
[TBL] [Abstract][Full Text] [Related]
14. Etiology of human breast cancer: a review.
MacMahon B; Cole P; Brown J
J Natl Cancer Inst; 1973 Jan; 50(1):21-42. PubMed ID: 4571238
[No Abstract] [Full Text] [Related]
15. Sounding board. Fibrocystic "disease" of the breast--a nondisease?
Love SM; Gelman RS; Silen W
N Engl J Med; 1982 Oct; 307(16):1010-4. PubMed ID: 7110289
[No Abstract] [Full Text] [Related]
16. Risk of breast cancer in women with benign breast disease.
Hutchinson WB; Thomas DB; Hamlin WB; Roth GJ; Peterson AV; Williams B
J Natl Cancer Inst; 1980 Jul; 65(1):13-20. PubMed ID: 6930509
[TBL] [Abstract][Full Text] [Related]
17. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
England PC; Sellwood RA; Knyba RE; Irvine JD
Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
[No Abstract] [Full Text] [Related]
18. [Breast cancer in Austria: epidemiology and risk factors].
Jakesz R; Schemper M; Friedl HP
Wien Klin Wochenschr; 1986 Jan; 98(1):1-7. PubMed ID: 3485327
[TBL] [Abstract][Full Text] [Related]
19. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
Bischoff J; Rebhan EM; Prestele H; Becker H
Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
Sokolova ZP
Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
